Inventor · Spring, TX, US

Charles Conrad

15Patents
4h-index
12Co-inventors
57Inventor score

Filing activity: Dec 18, 1992 → Jun 4, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8143412B2 Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs) Chemistry; Metallurgy 26 Active
US7137979B2 Methods and devices for the treatment of skin lesions Human Necessities 22 Expired
US8299033B2 Iodo-hexose compounds useful to treat cancer Human Necessities 13 Active
US5391458A Photoresist processing for improved resolution having a bake step to remove the tackiness of the laminated photosensitive layer prior to contact imagewise exposure Electricity 8 Expired
US8927506B2 Acetates of 2-deoxy monosaccharides with anticancer activity Human Necessities 4 Active
US9149489B2 Inhibitors of glycolysis useful in the treatment of brain tumors Human Necessities 3 Active
US10201554B2 Esters of 2-deoxy-monosacharides with anti proliferative activity Human Necessities 2 Active
US8450337B2 Methods of treating skin disorders with caffeic acid analogs Chemistry; Metallurgy 2 Active
US8182475B2 Methods and devices for the treatment of skin lesions Human Necessities 2 Active
US11026960B2 Esters of 2-deoxy-monosaccharides with anti proliferative activity Human Necessities 1 Active
US9000179B2 Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs) Chemistry; Metallurgy 1 Active
US8637675B2 Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS) Chemistry; Metallurgy 1 Active
US8779151B2 Orally bioavailable caffeic acid related anticancer drugs Chemistry; Metallurgy 1 Active
US10358439B2 DNA binding agents with a minor groove binding tail Chemistry; Metallurgy 0 Active
US11925654B2 Esters of 2-deoxy-monosaccharides with anti proliferative activity Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.